We Think That There Are Issues Underlying TG Therapeutics' (NASDAQ:TGTX) Earnings
Bilibili, MARA And ZEEKR Are Among Top 8 Mid-Cap Gainers Last Week (Mar 3-Mar 7): Are The Others In Your Portfolio?
Why TG Therapeutics Stock Was Soaring This Week
TG Therapeutics Call Volume Above Normal and Directionally Bullish
TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI (Ublituximab) in Multiple Sclerosis at the American Academy of Neurology 2025 Annual Meeting
B.Riley Financial Maintains TG Therapeutics(TGTX.US) With Buy Rating, Raises Target Price to $53
Do TG Therapeutics' (NASDAQ:TGTX) Earnings Warrant Your Attention?
A Quick Look at Today's Ratings for TG Therapeutics(TGTX.US), With a Forecast Between $10 to $55
Analysts Offer Insights on Healthcare Companies: TG Therapeutics (TGTX), BioLife Solutions (BLFS) and Surgery Partners (SGRY)
Cautious Outlook on TG Therapeutics Amid Competitive Pressures and Overvaluation Concerns
TG Therapeutics Analyst Ratings
Strong Financial Performance and Promising Outlook Drive Buy Rating for TG Therapeutics
Q4 2024 TG Therapeutics Inc Earnings Call
TG Therapeutics Earnings Call: Strong Growth Amid Challenges
TG Therapeutics | 10-K: FY2024 Annual Report
Earnings Call Summary | TG Therapeutics(TGTX.US) Q4 2024 Earnings Conference
TG Therapeutics (TGTX) Sees Significant Stock Surge After Financial Update
TG Therapeutics Shares Are Trading Higher After the Company Reported Better-than-expected Q4 Sales Results.
Sector Update: Health Care Stocks Advance Premarket Monday
TG THERAPEUTICS Earnings Results: $TGTX Reports Quarterly Earnings